hli logo
Image from Coce

Chimeric antigen receptor T-cell therapies for cancer : a practical guide / edited by Daniel W. Lee, Nirali N. Shah.

Contributor(s): Material type: TextTextPublisher: Amsterdam, Netherlands : Elsevier, [2020]Copyright date: ©2020Description: 1 online resource (xi, 222 pages) : illustrations (chiefly color)Content type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9780323755979
  • 0323755976
Subject(s): Genre/Form: Additional physical formats: Print version:: No titleDDC classification:
  • 571.9/66 23
LOC classification:
  • QR185.8.T2
NLM classification:
  • QW 574
Online resources:
Contents:
Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.
Item type: eBook List(s) this item appears in: National ClinicalKey eBooks
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Collection Shelving location Call number Status Date due Barcode Item holds
eBook eBook eLibrary eLibrary Health Library Ireland eBook Collection online ebook Available EB1620
Total holds: 0

Includes bibliographical references.

Introduction -- When to refer a patient for CAR-T cell therapy -- Optimizing the apheresis product -- CAR T cells: cell processing laboratory considerations -- Peri-CAR-T cell management -- Management of cytokine release syndrome -- Special considerations for ICU management of patients receiving CAR therapy -- Neurotoxicities after CAR-T cell immunotherapy -- Hematologic and non-CRS toxicities -- Response assessment and post-CAR-T cell therapy management -- Relapse management and role for consolidative hematopoietic stem cell transplantation following CAR-T cell therapy -- Promising chimeric antigen receptors for non-B cell hematological malignancies, pediatric solid tumors, and carcinomas -- CAR T cell therapy for CNS malignancies -- CAR 2.0: the next generation of synthetic receptor-based cellular therapy for cancer.

Online resource; title from electronic title page (ClinicalKey, viewed December 19, 2019).

Elsevier Elsevier ClinicalKey eBooks - WAYFless access

There are no comments on this title.

to post a comment.